|
OMIM |
Link |
Information gain |
01 |
|
myasthenia gravis with thymus hyperplasia
|
[NCBI]
|
0.000991404
|
|
|
IGAN1
|
[NCBI]
|
0.000614201
|
|
|
kabuki syndrome
|
[NCBI]
|
0.000510457
|
|
|
interleukin 2 receptor, alpha, deficiency of
|
[NCBI]
|
9.34065e-05
|
|
|
immunodeficiency with defective leukocyte and lymphocyte function and with response to histamine-1 antagonist
|
[NCBI]
|
8.79056e-05
|
|
|
RA
|
[NCBI]
|
8.06951e-05
|
|
|
complement factor i deficiency
|
[NCBI]
|
7.55373e-05
|
|
|
ectodermal dysplasia, hypohidrotic, with immune deficiency
|
[NCBI]
|
7.55373e-05
|
|
|
growth hormone insensitivity with immunodeficiency
|
[NCBI]
|
7.00994e-05
|
|
|
SGD
|
[NCBI]
|
6.72862e-05
|
|
|
HHS
|
[NCBI]
|
6.60454e-05
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
6.09734e-05
|
|
|
PECAM1
|
[NCBI]
|
6.03854e-05
|
|
|
IPEX
|
[NCBI]
|
5.93239e-05
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
5.52065e-05
|
|
|
CTCFL
|
[NCBI]
|
5.45026e-05
|
|
|
CD3G
|
[NCBI]
|
5.25043e-05
|
|
|
HSR
|
[NCBI]
|
5.08431e-05
|
|
|
HIGM1
|
[NCBI]
|
4.966e-05
|
|
|
CFD
|
[NCBI]
|
4.94215e-05
|
|
|
IRAK4
|
[NCBI]
|
4.94215e-05
|
|
|
LIP
|
[NCBI]
|
4.84347e-05
|
|
|
MNDA
|
[NCBI]
|
4.70756e-05
|
|
|
APAF1
|
[NCBI]
|
4.70756e-05
|
|
|
TNF
|
[NCBI]
|
4.46045e-05
|
|
|
ADA
|
[NCBI]
|
4.45102e-05
|
|
|
complement component 6 deficiency
|
[NCBI]
|
4.43556e-05
|
|
|
LHB
|
[NCBI]
|
4.43556e-05
|
|
|
STAT5B
|
[NCBI]
|
4.43556e-05
|
|
|
C5
|
[NCBI]
|
4.35935e-05
|
|
|
CRMO
|
[NCBI]
|
4.107e-05
|
|
|
IL2RA
|
[NCBI]
|
4.04771e-05
|
|
|
DKC1
|
[NCBI]
|
3.99571e-05
|
|
|
TNFSF8
|
[NCBI]
|
3.94632e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
3.94521e-05
|
|
|
LPI
|
[NCBI]
|
3.83938e-05
|
|
|
IL12B
|
[NCBI]
|
3.77044e-05
|
|
|
IKBKG
|
[NCBI]
|
3.62143e-05
|
|
|
HLA-A
|
[NCBI]
|
3.58748e-05
|
|
|
NP
|
[NCBI]
|
3.43351e-05
|
|
|
NGFB
|
[NCBI]
|
3.36032e-05
|
|
|
CD
|
[NCBI]
|
3.30186e-05
|
|
|
FOXP3
|
[NCBI]
|
3.0996e-05
|
|
|
EV
|
[NCBI]
|
2.76804e-05
|
|
|
SLE
|
[NCBI]
|
2.38287e-05
|
|
|
SST
|
[NCBI]
|
2.22703e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
1.77954e-05
|
|
|
INS
|
[NCBI]
|
1.70806e-05
|
|
|
CP
|
[NCBI]
|
1.6355e-05
|
|
|
MBL2
|
[NCBI]
|
1.57625e-05
|
|
|
CRH
|
[NCBI]
|
1.29416e-05
|
|
|
MG
|
[NCBI]
|
1.23476e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
8.48501e-06
|
|
|
MPO
|
[NCBI]
|
6.76423e-06
|
|
|
PD
|
[NCBI]
|
5.19648e-06
|
|
|
VIP
|
[NCBI]
|
4.46346e-06
|
|
|
HGF
|
[NCBI]
|
1.69721e-06
|
|
|
NPY
|
[NCBI]
|
1.59657e-06
|
|
|
MBP
|
[NCBI]
|
1.53487e-06
|
|
|
VEGF
|
[NCBI]
|
8.94322e-07
|
|
|
GFAP
|
[NCBI]
|
3.86815e-07
|
|
|
CRC
|
[NCBI]
|
5.71055e-08
|
|